-
Research funding: None declared.
-
Author contributions: All authors have accepted respon-sibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Not applicable.
-
Ethical approval: Not applicable.
References
1. Dimech, WJ, Vincini, GA, Plebani, M, Lippi, G, Nichols, JH, Sonntag, O. Time to address quality control processes applied to antibody testing for infectious diseases. Clin Chem Lab Med 2022 Nov 9. https://doi.org/10.1515/cclm.2022.0986 [Epub ahead of print].Search in Google Scholar
2. Dimech, W, Vincini, G, Karakaltsas, M. Determination of quality control limits for serological infectious disease testing using historical data. Clin Chem Lab Med 2015;53:329–36. https://doi.org/10.1515/cclm-2014-0546.Search in Google Scholar PubMed
3. Dimech, W, Walker, S, Jardine, D, Read, S, Smeh, K, Karakaltsas, K, et al.. Comprehensive quality control programme for serology and nucleic acid testing using an Internet-based application. Accred Qual Assur 2004;8:148–51. https://doi.org/10.1007/s00769-003-0734-5.Search in Google Scholar
4. Dimech, W. The standardization and control of serology and nucleic acid testing for infectious diseases. Clin Microbiol Rev 2021;34:e0003521. https://doi.org/10.1128/cmr.00035-21.Search in Google Scholar
© 2022 Walter de Gruyter GmbH, Berlin/Boston
